W Hotel,
Philadelphia, PA
2026 Year-End Summit
Preparing Compounders for 2027: Compliance, Quality, and Growth in a Shifting Market
The 2026 YEAR-END SUMMIT will provide timely insights from the last 12 months on FDA and state board enforcement trends, GLP-1 and peptide developments, telehealth and med spa partnerships, inspection readiness, and scalable quality systems to help compounders reduce risk, strengthen operations, and prepare for 2027.


Unleash Compounding Pharmacy Compliance Excellence
With insights gained from our community, we're thrilled to announce that the Year-End Compounding Pharmacy Compliance Summit will return for 2026! Whether you're a seasoned pro or a newcomer, get ready for an upgraded program to close out an active 2026! The agenda will once again be packed with cutting-edge topics designed to aid you in conquering the complex, ever-evolving regulatory guidelines and quality standards necessary to achieve success.
Don't just take our word for it — check out the content from this past December below!
GLP-1 Regulatory Oversight & Enforcement
- Stay ahead of FDA and state board scrutiny with the latest on GLP-1 oversight and enforcement priorities
- Understand essential copy provisions, lawsuits, and patent protections shaping the compliance landscape
- Learn how requirements differ for 503A vs. 503B pharmacies and prepare effectively for inspections
Quality Systems, Risk & Licensure
- Strengthen quality systems with proven practices in dosing, ingredient stability, and cold-chain shipping
- Reduce liability and recall risks with smarter QA/QC programs and risk management strategies
- Evaluate when multi-state licensure makes sense to expand safely and compliantly
Marketing, Messaging & Reputation
- Gain clarity on compliant GLP-1 messaging and avoid advertising missteps that trigger enforcement
- Learn the do’s and don’ts of provider outreach and patient communication
- Strengthen trust with providers and patients through transparency, education, and credibility
Supply Chain & Vendor Management
- Tackle sourcing challenges for APIs and excipients with strategies for vendor vetting and quality safeguards
- Safeguard ingredient integrity and reliability with end-to-end supplier quality checks
- Develop proactive strategies to manage ingredient shortages and maintain supply reliability for GLP-1 compounding
Telehealth Demand & Vertical Integration
- Address how telehealth demand is outpacing the capacity of compounding pharmacies
- Understand how this supply imbalance is driving telehealth players to open their own facilities
- Explore the risks and opportunities of vertical integration models for the compounding industry
Future Outlook & Strategic Planning
- Prepare for 2026 with insights on payer policies, reimbursement shifts, and market access trends
- Analyze manufacturer actions and competitive dynamics shaping compounded GLP-1s
- Position your organization for long-term growth and credibility with a clear strategic roadmap
See Who You'll Meet...
You will benefit from attending this event if you work at a Compounding Pharmacy, Compounding Pharmacy Distribution, Hospital System/Hospital Pharmacy or Government Group:
- Pharmacy Operations
- Pharmacy Services
- Pharmacist-In-Charge
- Owner/President/CEO
- Legal / Compliance
- Facilities Management
- Pharmacy Technicians
- Pharmacist/Pharmacy Operations
- Regulatory Affairs
- Quality/QA/QC
- President/Owner/C-Level
- Laboratory/Scientist
- Compliance
FAQs
What is the Compounding Pharmacy Compliance Year-End Summit?
The 2026 Year-End Summit delivers a comprehensive, year-end regulatory and compliance roadmap for compounding pharmacy owners, quality directors, and compliance leaders. It covers FDA and state board enforcement trends, GLP-1 and peptide developments, telehealth and med spa partnerships, inspection readiness, and scalable quality systems to help compounders reduce risk, strengthen operations, and prepare for 2027.
When and where is the Summit taking place?
The Compounding Pharmacy Compliance Year-End Summit will be held from December 9-10, 2026, at the W Hotel in Philadelphia, PA, USA.
Who should attend this Summit?
The Compounding Pharmacy Compliance Year-End Summit is ideal for leaders and professionals working in:
- Quality / Quality Assurance
- Pharmacy Operations
- Owner / President / CEO
- Lead Pharmacist / Pharmacist-In-Charge
- Compliance
- Facilities Management
- Regulatory Affairs
- Legal / Counsel
Is there an early registration discount available?
Yes, you can save $200 by registering before Friday, November 6th, 2026. Find out more on the Book Now page.
What topics will be covered at the Summit?
Through case studies, workshops, and interactive sessions, attendees gain actionable insights across these themes:
- Regulatory, Legislative and Market Forces Reshaping Compounding
- State Board Perspectives: What Regulators Are Seeing Across the Country and How to Manage Variability
- Updates on Peptides, GLP-1s and Emerging Therapies
- Telehealth Partnerships, Mergers and New Care Delivery Models
- Transitioning from 503A to 503B
- Navigating Supply Chain Relationships Across 503A, 503B, Telehealth and Med Spa Channels
These themes play out across a two-day agenda. Day One (December 9) includes the Industry Outlook Session on regulatory, legislative, and market forces; a panel on structuring compliant partnerships across 503A, 503B, telehealth, and med spa channels; a State Board Fireside Chat on inspection trends and enforcement priorities; a compliance briefing on managing state-by-state regulatory variability; a DEA disciplinary action case study; a regulatory update on peptides, GLP-1s, and emerging therapies (including the FDA's July review of 14 commonly compounded peptides); a session on AI and digital transformation in compounding operations; a strategic growth session on transitioning from 503A to 503B; and an A4PC industry update on advocacy and the future of compounding.
Day Two (December 10) covers a compliance leadership session on inspection readiness and sustainable quality systems; an executive case study on the business of compliance (balancing cGMP, QA, and infrastructure investment with profitability); a specialty spotlight on veterinary compounding compliance and growth; a session on compliant marketing and legal communication strategies for compounded drugs; sterile compounding operations and compliance essentials (USP less-than797greater-than and less-than800greater-than); and Executive Leadership Exchange Roundtables covering emerging business models, inspections and audits, scalable quality systems, peptides and GLP-1s, supply chain challenges, and future industry trends.
What is the format of the Compounding Year-End Summit?
The Summit is a 2-day, in-person event featuring expert-led sessions, case studies, workshops, panel discussions, a fireside chat, and facilitated roundtables. Attendees also get access to the ConnectMe Digital Platform and App, which includes video chat, instant messaging, and meeting request functionalities, plus recorded presentations available for 12 months on the Streamly digital platform, pending speaker permissions.
Will there be networking opportunities?
Yes. The agenda includes a networking breakfast each morning, networking and refreshment breaks throughout both days, a networking luncheon each day, as well as small-group roundtable discussions designed for candid, peer-to-peer dialogue and a networking reception at the close of Day One. The brochure also highlights unrivaled networking with colleagues and counterparts and a full attendee list accessible via the ConnectMe platform.
Why should I attend the Compounding Year-End Summit?
The Summit is positioned as the only event delivering a comprehensive, year-end regulatory and compliance roadmap specifically for compounding pharmacy owners, quality directors, and compliance leaders. Attendees hear from industry-leading voices such as Jamal Almustapha (Strive Pharmacy), Scott Welch (Preston's Pharmacy), Erika Fallon (Fallon Wellness Pharmacy), Scott Brunner (Alliance for Pharmacy Compounding), Melissa Stefko (Wells Pharmacy Network), and Timothy Fensky (Massachusetts Board of Registration in Pharmacy), among others, through case studies and interactive sessions designed to deliver practical, forward-looking solutions for sustainable compliance and operational excellence.
Does this Summit offer Continuing Education Credits
Yes, this event offers ACPE Credits for Pharmacists*
*pending approval
Who organizes the Compounding Year-End Summit
The summit is organized by Informa Connect, part of Informa PLC.
Where can I find the detailed agenda?
The detailed agenda is available to view here and to download below:


